Factor VIII Is Synthesized in Human Endothelial Cells, Packaged in Weibel-Palade Bodies and Secreted Bound to ULVWF Strings
Overview
Authors
Affiliations
The cellular synthesis site and ensuing storage location for human factor VIII (FVIII), the coagulation protein deficient in hemophilia A, has been elusive. FVIII stability and half-life is dependent on non-covalent complex formation with von Willebrand factor (VWF) to avoid proteolysis and clearance. VWF is synthesized in megakaryocytes and endothelial cells, and is stored and secreted from platelet alpha granules and Weibel-Palade bodies of endothelial cells. In this paper we provide direct evidence for FVIII synthesis in 2 types of primary human endothelial cells: glomerular microvascular endothelial cells (GMVECs) and umbilical vein endothelial cells (HUVECs). Gene expression quantified by real time PCR revealed that levels of F8 and VWF are similar in GMVECs and HUVECs. Previous clinical studies have shown that stimulation of vasopressin V2 receptors causes parallel secretion of both proteins. In this study, we found that both endothelial cell types express AVPR2 (vasopressin V2 receptor gene) and that AVPR2 mRNA levels are 5-fold higher in GMVECs than HUVECs. FVIII and VWF proteins were detected by fluorescent microscopy in Weibel-Palade bodies within GMVECs and HUVECs using antibodies proven to be target specific. Visual presence of FVIII and VWF in Weibel-Palade bodies was confirmed by correlation measurements. The high extent of correlation was compared with negative correlation values obtained from FVIII detection with cytoplasmic proteins, β-actin and Factor H. FVIII activity was positive in GMVEC and HUVEC cell lysates. Stimulated GMVECs and HUVECs were found to secrete cell-anchored ultra-large VWF strings covered with bound FVIII.
Rescue of the endogenous FVIII expression in hemophilia A mice using CRISPR-Cas9 mRNA LNPs.
Chen C, Cai X, Konkle B, Miao C Mol Ther Nucleic Acids. 2024; 35(4):102383.
PMID: 39640016 PMC: 11617921. DOI: 10.1016/j.omtn.2024.102383.
Dhinoja S, De Maria A, Al Qaryoute A, Jagadeeswaran P Blood Coagul Fibrinolysis. 2024; 35(5):238-247.
PMID: 38874909 PMC: 11230853. DOI: 10.1097/MBC.0000000000001308.
Hatch C, Piombo S, Fang J, Gach J, Ewald M, Van Trigt W Front Cardiovasc Med. 2024; 11:1360364.
PMID: 38576426 PMC: 10991679. DOI: 10.3389/fcvm.2024.1360364.
CD36 regulates factor VIII secretion from liver endothelial cells.
Reventun P, Toledano-Sanz P, Alcharani N, Viskadourou M, Morrison A, Sabater-Lleal M Blood Adv. 2023; 8(1):143-149.
PMID: 38157226 PMC: 10787269. DOI: 10.1182/bloodadvances.2023010023.
Non-viral and viral delivery systems for hemophilia A therapy: recent development and prospects.
Zangi A, Amiri A, Pazooki P, Soltanmohammadi F, Hamishehkar H, Javadzadeh Y Ann Hematol. 2023; 103(5):1493-1511.
PMID: 37951852 DOI: 10.1007/s00277-023-05459-0.